Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study

Patients with rheumatic diseases (RD) are considered to be a high-risk population for infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The effectiveness of inactivated COVID-19 vaccinations (ICVs) was described as more effective than 95%. Despite this, no data on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Huiqiong, Liu, Hanjiang, Liu, Zhi, Zhou, Xiakai, Lu, Xiaoping, Yan, Zhenbo, Zhou, Yan, Dai, Liping, Chen, Yashuo, Yang, Tingting, Yin, Zhihua, Ye, Zhizhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621074/
https://www.ncbi.nlm.nih.gov/pubmed/35878733
http://dx.doi.org/10.1080/21645515.2022.2090176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621074/
https://www.ncbi.nlm.nih.gov/pubmed/35878733
http://dx.doi.org/10.1080/21645515.2022.2090176

Ejemplares similares